Maia Kinnebrew

Maia Kinnebrew

Auto-generated profile, based on publicly available information

Maia Kinnebrew

Department of Biochemistry, Stanford University School of Medicine

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2019 in eLife
Verified
Journal Article
Open access
MKMaia Kinnebrew
Maia Kinnebrew
EIEllen J Iverson
Ellen J Iverson
BPBhaven B Patel
Bhaven B Patel
GPGanesh Pusapati
Ganesh Pusapati
JKJennifer H Kong
Jennifer H Kong
RRRajat Rohatgi
Rajat Rohatgi
Previously we proposed that transmission of the hedgehog signal across the plasma membrane by Smoothened is triggered by its interaction with cholesterol (Luchetti et al., 2016). But how is cholesterol, an abundant lipid, regulated tightly enough to control a signaling system that can cause birth defects and cancer? Using toxin-based sensors that distinguish between distinct pools of cholesterol, we find that Smoothened activation and hedgehog signaling are driven by a biochemically-defined, small fraction of membrane cholesterol, termed accessible cholesterol. Increasing cholesterol accessibility by depletion of sphingomyelin, which sequesters cholesterol in complexes, amplifies hedgehog signaling. Hedgehog ligands increase cholesterol accessibility in the membrane of the primary cilium by inactivating the transporter-like protein Patched 1. Trapping this accessible cholesterol blocks hedgehog signal transmission across the membrane. Our work shows that the organization of cholesterol in the ciliary membrane can be modified by extracellular ligands to control the activity of cilia-localized signaling proteins.

17 March 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
DGDavid Gokhman
David Gokhman
RARachel M. Agoglia
Rachel M. Agoglia
MKMaia Kinnebrew
Maia Kinnebrew
WGWei Gordon
Wei Gordon
DSDanqiong Sun
Danqiong Sun
HFHunter B. Fraser
Hunter B. Fraser

26 October 2021 in eLife
Verified
Journal Article
Open access
MKMaia Kinnebrew
Maia Kinnebrew
GLGiovanni Luchetti
Giovanni Luchetti
RSRia Sircar
Ria Sircar
SFSara Frigui
Sara Frigui
LVLucrezia Vittoria Viti
Lucrezia Vittoria Viti
RRRajat Rohatgi
Rajat Rohatgi
A long-standing mystery in vertebrate Hedgehog signaling is how Patched 1 (PTCH1), the receptor for Hedgehog ligands, inhibits the activity of Smoothened, the protein that transmits the signal across the membrane. We previously proposed (Kinnebrew et al., 2019) that PTCH1 inhibits Smoothened by depleting accessible cholesterol from the ciliary membrane. Using a new imaging-based assay to directly measure the transport activity of PTCH1, we find that PTCH1 depletes accessible cholesterol from the outer leaflet of the plasma membrane. This transport activity is terminated by binding of Hedgehog ligands to PTCH1 or by dissipation of the transmembrane potassium gradient. These results point to the unexpected model that PTCH1 moves cholesterol from the outer to the inner leaflet of the membrane in exchange for potassium ion export in the opposite direction. Our study provides a plausible solution for how PTCH1 inhibits SMO by changing the organization of cholesterol in membranes and establishes a general framework for studying how proteins change cholesterol accessibility to regulate membrane-dependent processes in cells.

3 June 2022 in Science Advances
Verified
Journal Article
Open access
MKMaia Kinnebrew
Maia Kinnebrew
RWRachel E. Woolley
Rachel E. Woolley
TAT. Bertie Ansell
T. Bertie Ansell
EBEamon F. X. Byrne
Eamon F. X. Byrne
SFSara Frigui
Sara Frigui
RRRajat Rohatgi
Rajat Rohatgi
Smoothened (SMO) transduces the Hedgehog (Hh) signal across the plasma membrane in response to accessible cholesterol. Cholesterol binds SMO at two sites: one in the extracellular cysteine-rich domain (CRD) and a second in the transmembrane domain (TMD). How these two sterol-binding sites mediate SMO activation in response to the ligand Sonic Hedgehog (SHH) remains unknown. We find that mutations in the CRD (but not the TMD) reduce the fold increase in SMO activity triggered by SHH. SHH also promotes the photocrosslinking of a sterol analog to the CRD in intact cells. In contrast, sterol binding to the TMD site boosts SMO activity regardless of SHH exposure. Mutational and computational analyses show that these sites are in allosteric communication despite being 45 angstroms apart. Hence, sterols function as both SHH-regulated orthosteric ligands at the CRD and allosteric ligands at the TMD to regulate SMO activity and Hh signaling.

21 February 2025 in Science Advances
Verified
Journal Article
Open access
CKChandni B. Khandwala
Chandni B. Khandwala
PSPARIJAT SARKAR
PARIJAT SARKAR
HSH. Broder Schmidt
H. Broder Schmidt
MMMengxiao Ma
Mengxiao Ma
GPGanesh Pusapati
Ganesh Pusapati
RRRajat Rohatgi
Rajat Rohatgi
Rising temperatures and water scarcity caused by climate change are increasingly exposing our cells and tissues to ionic stress, a consequence of elevated cytoplasmic ionic strength that can disrupt protein, organelle, and genome function. Here, we unveil a single-protein mechanism for ionic strength sensing and mitigation in animal cells, one that is notably different from the analogous high osmolarity glycerol kinase cascade in yeast. The Rel family transcription factor NFAT5 directly senses intracellular ionic strength using a C-terminal prion-like domain (PLD). In response to elevated intracellular ionic strength, this PLD is necessary and sufficient to coordinate an adaptive gene expression program by recruiting the transcriptional coactivator BRD4. The purified NFAT5 PLD forms condensates in response to elevated solution ionic strength in vitro, and human NFAT5 alone is sufficient to reconstitute a mammalian transcriptional response to ionic stress in yeast. We propose that ion-sensitive conformational changes in a PLD directly regulate transcription to maintain ionic strength homeostasis in animal cells.

25 August 2023 in Science Advances
Verified
Journal Article
Open access
TAT. Bertie Ansell
T. Bertie Ansell
RCRobin A. Corey
Robin A. Corey
LVLucrezia Vittoria Viti
Lucrezia Vittoria Viti
MKMaia Kinnebrew
Maia Kinnebrew
RRRajat Rohatgi
Rajat Rohatgi
MSMark Sansom
Mark Sansom
Patched1 (PTCH1) is a tumor suppressor protein of the mammalian Hedgehog (HH) signaling pathway, implicated in embryogenesis and tissue homeostasis. PTCH1 inhibits the G protein–coupled receptor Smoothened (SMO) via a debated mechanism involving modulating ciliary cholesterol accessibility. Using extensive molecular dynamics simulations and free energy calculations to evaluate cholesterol transport through PTCH1, we find an energetic barrier of ~15 to 20 kilojoule per mole for cholesterol export. In silico data are coupled to in vivo biochemical assays of PTCH1 mutants to probe coupling between cation binding sites, transmembrane motions, and PTCH1 activity. Using complementary simulations of Dispatched1, we find that transition between “inward-open” and solvent “occluded” states is accompanied by Na + -induced pinching of intracellular helical segments. Thus, our findings illuminate the energetics and ion coupling stoichiometries of PTCH1 transport mechanisms, whereby one to three Na + or two to three K + couple to cholesterol export, and provide the first molecular description of transitions between distinct transport states.